Gurnet Point Capital’s Acquisition of Paratek Pharmaceuticals

Marco Zingaro
Tagged:

Latham & Watkins advises Gurnet Point Capital in acquisition of Paratek Pharmaceuticals.Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

…

This content is for Standard 1 Year members only.
Login Join Now